Back to
GOLDMAN SACHS GROUP INC
TORCNShowing 6 of 15 quarters
Position history for
GOLDMAN SACHS GROUP INC's holdings in ADICET BIO INC
As of its Q3 2025 13F, Goldman Sachs held 3,751,617 shares of TORCN (Adicet Bio), worth $3M. Goldman Sachs' 13F filings listed TORCN from Q2 2022 to Q3 2025, 14 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$5.4M
Total Shares Change
-3.8M
Quarter-by-Quarter History
Other major holders of TORCN: RTW INVESTMENTS, LP